IP Library Granted Patent US 9,102,989
Granted Patent B2
US 9,102,989 · App. 12/244,677 · Granted Aug 11, 2015

Non-revertible β-oxidation blocked

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,102,989
App. No.
12/244,677
Granted
Aug 11, 2015
Kind
B2
Abstract

Genetically modified strains of C. tropicalis , which will not revert to wild-type activity at the POX 4 and/or POX 5 locus, are disclosed. The strains are β-oxidation blocked and have been transformed through homologous recombination with a construct which deletes a portion of the POX 4 and/or POX 5 gene. The modified strains may be used to increase yields of dicarboxylic acids produced in host cells of the strains. Methods for blocking the β-oxidation pathway in a C. tropicalis host cell are also provided.

Claims (6)

1. A Candida tropicalis cell derived from Candida tropicalis strain H53 by deletion of a 653 base pair portion of a coding region of a POX 4 gene open reading frame of strain H53 and insertion of a 1676 base pair URA 3 marker gene in the POX 4 coding region, wherein the cell is a cell of strain HDC100.

2. A process for producing a substantially pure α,ω-dicarboxylic acid which comprises culturing the Candida tropicalis cell of claim 1 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

3. A Candida tropicalis cell of strain HDC100.

4. A process for producing a substantially pure α,ω-dicarboxylic acid which comprises culturing the Candida tropicalis cell of claim 3 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

5. A Candida tropicalis cell of strain HDC100 deposited under Accession No. DSM19688.

6. A process for producing a substantially pure α,ω-dicarboxylic acid which comprises culturing the Candida tropicalis cell of claim 5 in a culture medium containing a nitrogen source, an organic substrate and a cosubstrate.

Assignments (1)
PATENT AND TRADEMARK TRANSFER AGREEMENT Recorded Aug 19, 2010
From: COGNIS CORPORATION
To: COGNIS IP MANAGEMENT GMBH
Reel/Frame 024850/0512 →